SEC Form 4 · accession 0000784199-17-000027
ARTIVION, INC. · AORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott B Capps
Officer — VP, Clinical Research
Period of report
Feb 22, 2017
Accepted (ET)
Feb 24, 2017 · 9:10 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000784199
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2017 | M | 16,667 | $7.01 | A | 128,477 | D | |
| Common StockF2 | Feb 22, 2017 | S | 11,083 | $16.4013 | D | 117,394 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $7.01 | Feb 22, 2017 | M | 16,667 | D | Feb 22, 2011 | Feb 22, 2017 | Common Stock | 16,667 | 0 | D |
Explanation of responses
- F1Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/22/2011
- F2Reflects weighted average price. Range was $16.35 to $16.45 The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.